According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $1.52. In 2022 the company made an earnings per share (EPS) of $1.06 an increase over its 2021 EPS that were of $0.14.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.52 | 42.92% |
2022 | $1.06 | 631.03% |
2021 | $0.14 | -88.11% |
2020 | $1.22 | 136.89% |
2019 | $0.51 | -39.41% |
2018 | $0.85 | -28.27% |
2017 | $1.18 | -14.37% |
2016 | $1.38 | 24.11% |
2015 | $1.12 | 127.55% |
2014 | $0.49 | -51.96% |
2013 | $1.02 | -58.95% |
2012 | $2.48 | -32.2% |
2011 | $3.66 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $4.84 | 219.56% | ๐บ๐ธ USA |
![]() Novartis NVS | $3.28 | 116.50% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $5.18 | 241.91% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $3.66 | 141.26% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $6.82 | 350.12% | ๐บ๐ธ USA |
![]() Sanofi SNY | $2.85 | 87.80% | ๐ซ๐ท France |
![]() Biogen BIIB | $21.62 | 1,327.06% | ๐บ๐ธ USA |
![]() Merck MRK | $5.73 | 278.22% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $3.46 | 128.38% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $8.03 | 430.18% | ๐ฌ๐ง UK |